Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000346157

Medchemexpress LLC 1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aS)- | 1323077-88-8 | 99.7% | 377.40 | 1 MG
SDP

Catalog No. 5000346157
Encompass_Preferred

Enzaplatovir (BTA-C585) is an orally bioavailable inhibitor for respiratory syncytial virus (RSV) infection and is described as a small-molecule RSV entry inhibitor. It is used for respiratory syncytial virus (RSV) infection and is relevant for RSV-associated lower respiratory tract infection (LRTI).

  • Orally bioavailable
  • Inhibitor for respiratory syncytial virus (RSV) infection
  • Small-molecule RSV entry inhibitor
  • Used for respiratory syncytial virus infection
  • Relevant for RSV-associated lower respiratory tract infection (LRTI)

Catalog No. 50-003-46157 Supplier Medchemexpress LLC Supplier No. HY109004A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Enzaplatovir (BTA-C585) is an orally bioavailable inhibitor for respiratory syncytial virus (RSV) infection and is described as a small-molecule RSV entry inhibitor. It is used for respiratory syncytial virus (RSV) infection and is relevant for RSV-associated lower respiratory tract infection (LRTI).

  • Orally bioavailable
  • Inhibitor for respiratory syncytial virus (RSV) infection
  • Small-molecule RSV entry inhibitor
  • Used for respiratory syncytial virus infection
  • Relevant for RSV-associated lower respiratory tract infection (LRTI)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.